GlivecImatinib100 mg120Tablets All Europe delivery. Shipping time 7-10 days. Price for shipping individual for each country. Usually 40-50 euro. Payment when sending the goods. \r\n Worldwide shipping possible too. \r\n Interchangeable drugs with the same active ingredient: \r\n \r\n Alvotinib \r\n Vinat \r\n Vinat 100 \r\n Vinat-100-Health \r\n Glivec \r\n Imatib \r\n Imatinib Actavis \r\n Imatinib Grindeks \r\n Imatinib Zentiva \r\n Imatinib Medak \r\n Imatinib-Teva \r\n Myelofar \r\n neopax \r\n \r\n Indications \r\n \r\n Treatment of patients (adults and children) with newly diagnosed chronic myeloid leukemia; \r\n Treatment of patients (adults and children) with chronic myeloid leukemia in the blast crisis phase and the acceleration pha...
All Europe delivery. Shipping time 7-10 days. Price for shipping individual for each country. Usually 40-50 euro. Payment when sending the goods.
Worldwide shipping possible too.
Interchangeable drugs with the same active ingredient:
Alvotinib
Vinat
Vinat 100
Vinat-100-Health
Glivec
Imatib
Imatinib Actavis
Imatinib Grindeks
Imatinib Zentiva
Imatinib Medak
Imatinib-Teva
Myelofar
neopax
Indications
Treatment of patients (adults and children) with newly diagnosed chronic myeloid leukemia;
Treatment of patients (adults and children) with chronic myeloid leukemia in the blast crisis phase and the acceleration phase and in the chronic phase after unsuccessful therapy with interferon alfa;
Treatment of adult patients with newly diagnosed positive (with the presence in the leukocytes of the Philadelphia chromosome (bcr-abl) acute lymphoblastic leukemia as part of chemotherapy;
Treatment of adult patients with acute lymphoblastic leukemia in the stage of relapse or with persistent tolerance to chemotherapy as monotherapy;
Treatment of adult patients with myelodysplastic / myeloproliferative diseases associated with platelet growth factor receptor activation;
Treatment of adult patients with systemic mastocytosis with no D816B c-Kit mutations or no evidence of c-Kit mutational status;
Treatment of adults with hypereosinophilic syndrome and/or chronic ezosinophilic leukemia;
Treatment of adult patients with Kit (CD117) positive inoperable and / or metastatic malignant tumors of the stroma of the digestive tract;
637566862;6;632532028;7.3
Treatment of patients with unresectable and/or metastatic dermatofibrosarcoma.
